Inventor · disambiguated record
Qingming Zhu
Also filed as: ZHU QINGMING
17 granted patents·6 pending applications·48 citations·filing 2004–2024
91Inventor score
Files withGILEAD SCIENCES INC7BAYER PHARMACEUTICALS CORP5NOVARTIS AG5BAYER HEALTHCARE LLC2AULAKH VIRENDER SINGH1
Top patents by PatentIndex Score
23 records- 0192US11667652B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2020·Granted Jun 6, 2023·2 cites·15 claims
- 0290US12054490B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2023·Granted Aug 6, 2024·1 cites·20 claims
- 0389US11845723B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2020·Granted Dec 19, 2023·3 cites·41 claims
- 0488US11976072B2Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 7, 2024·1 cites·19 claims
- 0586US7511048B2PyrimidothienoindazolesBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Mar 31, 2009·4 cites·10 claims
- 0685US7557129B2Cyanopyridine derivatives useful in the treatment of cancer and other disordersBAYER HEALTHCARE LLC·Filed 2004·Granted Jul 7, 2009·18 cites·18 claims
- 0782US10369138B2Monobactam organic compounds for the treatment of bacterial infectionsNOVARTIS AG·Filed 2015·Granted Aug 6, 2019·3 cites·17 claims
- 0881US9174978B2Monobactam organic compounds for the treatment of bacterial infectionsAULAKH VIRENDER SINGH·Filed 2015·Granted Nov 3, 2015·5 cites·24 claims
- 0981US2025197421A1Mcl1 inhibitorsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1080US2025361236A9Diacylglycerol kinase modulating compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1178US10065957B2Beta-lactamase inhibitorsNOVARTIS AG·Filed 2017·Granted Sep 4, 2018·1 cites·18 claims
- 1278US8076488B2Bicyclic urea derivatives useful in the treatment of cancer and other disordersDUMAS JACQUES·Filed 2004·Granted Dec 13, 2011·10 cites·32 claims
- 1377US12202842B2MCL1 inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Jan 21, 2025·0 cites·8 claims
- 1469US7803956B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Granted Sep 28, 2010·0 cites·19 claims
- 1567US7659412B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2008·Granted Feb 9, 2010·0 cites·8 claims
- 1664US2020276169A1Monobactam organic compounds for the treatment of bacterial infectionsNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1764US2009186887A1Novel pyrimidothienoindazolesBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 1862US10597396B2Beta-lactamase inhibitorsNOVARTIS AG·Filed 2017·Granted Mar 24, 2020·0 cites·20 claims
- 1961US2019231752A1Monobactam organic compounds for the treatment of bacterial infectionsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2054US7420066B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 2, 2008·0 cites·7 claims
- 2150US2011092505A1Organic compoundsBURGIS ROBIN·Filed 2009·Application pending·0 cites
- 2246US7238701B2Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Jul 3, 2007·0 cites·7 claims
- 2343US8207172B2Pyrimidinothienoindazoles useful for the treatment of hyperproliferative disordersZHANG CHENGZHI·Filed 2005·Granted Jun 26, 2012·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Qingming Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →